# Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Metastatic Malignant Solid Neoplasm

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05687110

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.